Hosted on MSN2mon
Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?In this article, we are going to take a look at where Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) stands against the other small-cap biotech stocks. The biotechnology sector is expanding ...
Shares of CRBP stock opened at $11.30 on Monday. Corbus Pharmaceuticals has a 52-week low of $5.67 and a 52-week high of $61.90. The stock has a market cap of $137.62 million, a price-to-earnings ...
CRBP stock opened at $11.79 on Monday. The business has a 50 day moving average price of $15.40 and a 200 day moving average price of $32.95. The stock has a market cap of $143.59 million, a price ...
Piper Sandler analyst Biren Amin maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today and set a price target of $35.00. The company’s shares closed yesterday at $9.90.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results